Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Astelin nasal spray cost?Dupixent ablauf patent?When the patent of trikafta expires?Zarontin generic name?Cost of focalin xr without insurance?
See the DrugPatentWatch profile for Atezolizumab
Atezolizumab is marketed by Genentech (Roche). It is sold in the U.S. under the brand name Tecentriq.
Although Genentech markets atezolizumab, the product is part of the broader Roche/Genentech ecosystem, and Roche is the parent company. This is the basis for how the drug is commonly described in regulatory and market references.
If you’re looking for patent timelines, exclusivity, or generic/biosimilar risk tracking tied to atezolizumab, DrugPatentWatch.com compiles these details and updates them as filings or legal events change. Source: DrugPatentWatch – Atezolizumab
Yes—search results often show different entities depending on whether you mean: - the marketing/brand owner (Genentech), - the parent company (Roche), - the specific manufacturer of clinical supplies in older trials, - or the company challenging or litigating related patents. If you tell me what you mean by “company” (maker/brand owner, manufacturer, or patent holder), I can narrow it to the exact entity.
Other Questions About Atezolizumab :